Skip to main content

Table 2 Laboratory test results

From: Clinical characteristics and prognosis of patients with isolated thrombotic vs. obstetric antiphospholipid syndrome: a prospective cohort study

 

IoAPS

(n = 44)

ItAPS

(n = 39)

tAPS+oAPS

(n = 9)

P value

All groups

P value

IoAPS vs. ItAPS

Antibody categories

     

 Triple positive, n (%)

11 (25.00)

18 (46.15)

6 (66.67)

0.022

0.065

 Double positive, n (%)

7 (15.90)

9 (23.08)

1 (11.11)

0.678

0.578

  ACL+LA

0 (0)

1 (2.56)

0 (0)

0.521

0.470

  LA+anti-β2GPI

2 (4.55)

2 (5.13)

1 (11.11)

0.632

1.000

  ACL+anti-β2GPI

5 (11.36)

6 (15.38)

0 (0)

0.651

0.748

 Single positive, n (%)

26 (59.10)

12 (30.77)

2 (22.22)

0.017

0.015

  ACL

1 (2.27)

1 (2.56)

0 (0)

1.000

1.000

  Anti-β2GPI

23 (52.27)

7 (17.94)

1 (11.11)

0.001

0.001

  LA

2 (4.55)

4 (10.26)

1 (11.11)

0.420

0.413

ESR (mm/h), median (quartile)

10 (6, 27)

10 (5,21)

11 (4.5,27.5)

0.814

0.254

CRP (mg/L), median (quartile)

1.03 (0.56, 3.85)

1.32 (0.50,3.92)

9.55 (0.46,10.95)

0.808

0.383

Hcy (μmol/L), median (quartile)

9.90 (8.10, 12.10)

11.20 (9.70,14.60)

10.85 (9.08,12.68)

0.152

0.028

C3 (g/L), median (quartile)

0.98 (0.81, 1.17)

0.92 (0.73,1.12)

0.75 (0.66,1.11)

0.235

0.129

C4 (g/L), median (quartile)

0.16 (0.13, 0.23)

0.17 (0.13,0.21)

0.14 (0.12,0.18)

0.565

0.371

  1. ACL, anticardiolipin antibody; anti-β2GPI, anti-β2 glycoprotein I antibody; LA, lupus anticoagulant; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; Hcy, homocysteine; C3, complement C3; C4, complement C4